Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28777983

CC(C)(C)OC=O.Nc1ccc(CN2CCNCC2)cc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
CXCR4 P61073 12/20 0.47
MEN1 O00255 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
ADRA2C P18825 1/20 0.47
CCR2 P41597 1/20 0.47
CXCL12 P48061 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
SIGMAR1 Q99720 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PLK4 O00444 1/20 0.41
CRBN Q96SW2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27993846 0.88 CXCR4 (0.48) CXCR4MEN1CHRM2CHRM1ADRA2C
Tert-Butyl Formate SCHEMBL27981789 0.86 CXCR4 (0.47) LMNACXCR4MEN1CHRM2CHRM1
Tert-Butyl Formate SCHEMBL27524789 0.86 SIGMAR1 (0.66) LMNACXCR4MEN1CHRM2CHRM1
Tert-Butyl Formate SCHEMBL28055969 0.85 CHRM3 (0.49) CXCR4CHRM2SIGMAR1
Tert-Butyl Formate SCHEMBL28277617 0.85 CXCR4 (0.43) CXCR4MEN1CHRM2CHRM1ADRA2C
Tert-Butyl Formate SCHEMBL28277618 0.85 CXCR4 (0.43) CXCR4MEN1CHRM2CHRM1ADRA2C
Tert-Butyl Formate SCHEMBL27844700 0.84 HPGD (0.51) CXCR4MEN1CHRM2CHRM1ADRA2C
Ethoxycarbonyl Group SCHEMBL27721350 0.84 LMNA (0.48) LMNACXCR4MEN1CHRM2CHRM1
Tert-Butyl Formate SCHEMBL27659431 0.84 TNKS (0.41) LMNACXCR4MEN1CHRM2CHRM1
Tert-Butyl Formate SCHEMBL27844210 0.84 ACVR1 (0.39) CXCR4MEN1CHRM2CHRM1ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103626742-A Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN INC 2014-03-12 CN disclosed
CN-101981036-B Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors NOVARTIS AG 2013-09-04 CN disclosed
CN-101370792-B Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN INC 2013-03-20 CN disclosed
CN-101506155-A Biphenyl derivatives and their use in the treatment of hepatitis C ARROW THERAPEUTICS LTD (GB) 2009-08-12 CN disclosed
CN-101370792-A Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN INC (US) 2009-02-18 CN disclosed